Journal de la nanomédecine et de la nanotechnologie

Abstrait

Utility of Nanomedicine for Cancer Treatment

Akakuru OU, Louis H, Oyebanji OO, Ita BI, Amos PI and Philip M

The conventionally available cancer therapies present intrinsic limits which have prompted the development and application of nanotechnology which offer a promising effective and safer treatment. This has resulted in the development of cancer nanomedicine which has allowed researchers to improve techniques for delivering chemotherapeutic agents precisely at the molecular level in tumor tissues. This entails the use of nano-scale objects themselves or part of larger devices containing multiple nano-scale objects. Recently, most Bioscience fields use nanotechnology which has the impact on biomedicine and has potential to change the conventional cancer diagnosis and treatment. Commercial trials have begun on nano-based cancer therapies and diagnosis, however, others are still under development. Today, cytotoxic drugs can be efficiently delivered to tumor tissues using nanocarriers like nanoparticles which depend on difficult concepts of pharmacology. Multiple drugs can also be developed at the cancer site using nanomedicine which presents better cytotoxic effects. Nanomedicine also presents a targeted chemotherapeutic method under cytlmmune science which is still a developing field. This field enables the selective delivery of drugs at the cancer site, due to increased permeability of the blood vessels at the tumor sites. In our review, we focused on the anticancer nanomedicine scope.